NCT04460586 - Pharmacokinetics of Omadacycline in Cystic Fibrosis | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

July 1, 2021

Primary Completion Date

December 1, 2023

Study Completion Date

December 31, 2023

Conditions

Cystic Fibrosis

Interventions

DRUG

Omadacycline Injection [Nuzyra]

Participants will receive single dose of omadacycline 100mg IV followed by a 1-week washout and receipt of single dose omadacycline 300 mg PO.

DRUG

Omadacycline Oral Tablet [Nuzyra]

Participants will receive single dose of omadacycline 100mg IV followed by a 1-week washout and receipt of single dose omadacycline 300 mg PO.

Trial Locations (1)

University of Southern California, Los Angeles